Fajuan Rui

1.8k total citations · 1 hit paper
22 papers, 589 citations indexed

About

Fajuan Rui is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Fajuan Rui has authored 22 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 8 papers in Hepatology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Fajuan Rui's work include Liver Disease Diagnosis and Treatment (16 papers), Diet, Metabolism, and Disease (6 papers) and Hepatitis B Virus Studies (6 papers). Fajuan Rui is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Diet, Metabolism, and Disease (6 papers) and Hepatitis B Virus Studies (6 papers). Fajuan Rui collaborates with scholars based in China, United States and South Korea. Fajuan Rui's co-authors include Jie Li, Hongli Yang, Ramsey Cheung, Biyao Zou, Mindie H. Nguyen, Linda Henry, Chuanli Liu, Wan Hui, Hua Chun Zeng and Xiaohe Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Hepatology.

In The Last Decade

Fajuan Rui

19 papers receiving 572 citations

Hit Papers

Epidemiology of COVID‐19: A systematic review and meta‐an... 2020 2026 2022 2024 2020 100 200 300 400

Peers

Fajuan Rui
Fajuan Rui
Citations per year, relative to Fajuan Rui Fajuan Rui (= 1×) peers Shivam Khare

Countries citing papers authored by Fajuan Rui

Since Specialization
Citations

This map shows the geographic impact of Fajuan Rui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fajuan Rui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fajuan Rui more than expected).

Fields of papers citing papers by Fajuan Rui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fajuan Rui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fajuan Rui. The network helps show where Fajuan Rui may publish in the future.

Co-authorship network of co-authors of Fajuan Rui

This figure shows the co-authorship network connecting the top 25 collaborators of Fajuan Rui. A scholar is included among the top collaborators of Fajuan Rui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fajuan Rui. Fajuan Rui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yeo, Yee Hui, Xiang Gao, Fajuan Rui, et al.. (2025). Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): A Population‐Based Cohort Study. Alimentary Pharmacology & Therapeutics. 62(2). 168–179. 5 indexed citations
5.
Xu, Xiaoming, et al.. (2024). A Novel Algorithm for Streamlining Diagnosis of Advanced Liver Fibrosis in CHB Patients with Concurrent Hepatic Steatosis. Journal of Clinical and Translational Hepatology. 0(0). 0–0.
6.
Xu, Xiaoming, Zhiwen Fan, Xiaoyan Ma, et al.. (2024). Different minimal alcohol consumption in male and female individuals with metabolic dysfunction‐associated fatty liver disease. Liver International. 44(3). 865–875. 3 indexed citations
7.
Yin, Shengxia, Xin Tong, Fajuan Rui, et al.. (2024). Current research insights into the role of CTLA‐4 in hepatitis B virus (HBV) infection. Journal of Viral Hepatitis. 31(9). 557–564. 1 indexed citations
8.
Ma, Xiaoyan, Yee Hui Yeo, Zhiwen Fan, et al.. (2024). The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetes. Hepatology International. 18(3). 952–963. 3 indexed citations
9.
Xu, Xiao‐Ming, et al.. (2024). Spleen stiffness measurement as a non-invasive assessment in patients with portal hypertension. SHILAP Revista de lepidopterología. 2(1). e100031–e100031. 2 indexed citations
10.
Rui, Fajuan, Elizabeth García, Xinyu Hu, et al.. (2024). Antiviral therapy response in patients with chronic hepatitis B and fatty liver: A systematic review and meta‐analysis. Journal of Viral Hepatitis. 31(7). 372–382. 3 indexed citations
11.
Carr, Brian I., Fajuan Rui, Volkan İnce, et al.. (2023). Comparison of patients with hepatitis B virus‐associated hepatocellular carcinoma: Data from two hospitals from Turkey and China. PubMed. 2(4). 165–170. 2 indexed citations
13.
Yang, Hongli, Fajuan Rui, Shengxia Yin, et al.. (2022). ADAR1 Inhibits HBV DNA Replication via Regulating miR-122-5p in Palmitic Acid Treated HepG2.2.15 Cells. Diabetes Metabolic Syndrome and Obesity. Volume 15. 4035–4047. 4 indexed citations
14.
Liu, Chuanli, Hongli Yang, Yuemin Feng, et al.. (2022). A K-nearest Neighbor Model to Predict Early Recurrence of Hepatocellular Carcinoma After Resection. Journal of Clinical and Translational Hepatology. 10(4). 600–607. 9 indexed citations
15.
Tran, Andrew, Jie Li, Fajuan Rui, et al.. (2022). Increased Risk of Liver-Related Outcomes in Chronic Hepatitis B Patients with Metabolic Syndrome: A Systematic Review and Meta-Analysis. Digestive Diseases. 40(6). 745–753. 4 indexed citations
16.
Li, Jie, Fajuan Rui, Biyao Zou, et al.. (2022). Meta‐analysis: global prevalence, trend and forecasting of non‐alcoholic fatty liver disease in children and adolescents, 2000–2021. Alimentary Pharmacology & Therapeutics. 56(3). 396–406. 74 indexed citations
17.
Rui, Fajuan, Hongli Yang, Xinyu Hu, et al.. (2022). Renaming NAFLD to MAFLD: Advantages and Potential Changes in Diagnosis, Pathophysiology, Treatment, and Management. SHILAP Revista de lepidopterología. 4(2). 49–55. 6 indexed citations
18.
Li, Jie, Eileen L. Yoon, Sang Bong Ahn, et al.. (2021). NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea. Digestive Diseases. 39(6). 634–645. 31 indexed citations
19.
Rui, Fajuan, Hongli Yang, Zhaoyang Guo, et al.. (2021). Derivation and validation of prognostic models for predicting survival outcomes in Acute‐on‐chronic liver failure patients. Journal of Viral Hepatitis. 28(12). 1719–1728. 4 indexed citations
20.
Li, Jie, Daniel Q. Huang, Biyao Zou, et al.. (2020). Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomes. Journal of Medical Virology. 93(3). 1449–1458. 434 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026